Tag Archives: Dr. Reddy’s

March, 2016

• 28 March

  Dr. Reddy’s Gains US Rights to XenoPort’s Psoriasis Candidate XP23829

  

  HYDERABAD, India & SANTA CLARA, Calif.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc. (NASDAQ: XNPT) announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage …

  Share

  • Facebook
  • Twitter
  • LinkedIn
• 11 March

  Dr. Reddy’s and TR-Pharm Announce Biosimilars Collaboration in Turkey

  

  HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s and TR-Pharm announced today a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialized as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon completion of …

  Share

  • Facebook
  • Twitter
  • LinkedIn